These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32375681)

  • 21. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.
    Brück K; Jager KJ; Zoccali C; Bello AK; Minutolo R; Ioannou K; Verbeke F; Völzke H; Arnlöv J; Leonardis D; Ferraro PM; Brenner H; Caplin B; Kalra PA; Wanner C; Castelao AM; Gorriz JL; Hallan S; Rothenbacher D; Gibertoni D; De Nicola L; Heinze G; Van Biesen W; Stel VS;
    Kidney Int; 2018 Jun; 93(6):1432-1441. PubMed ID: 29656901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum sodium concentration and the progression of established chronic kidney disease.
    Cole NI; Suckling RJ; Desilva V; He FJ; MacGregor GA; Swift PA
    J Nephrol; 2019 Apr; 32(2):259-264. PubMed ID: 30328093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.
    Xie Y; Bowe B; Xian H; Balasubramanian S; Al-Aly Z
    Am J Kidney Dis; 2016 Aug; 68(2):219-228. PubMed ID: 26948835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
    Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
    Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum sodium levels and patient outcomes in an ambulatory clinic-based chronic kidney disease cohort.
    Han SW; Tilea A; Gillespie BW; Finkelstein FO; Kiser MA; Eisele G; Kotanko P; Levin N; Saran R
    Am J Nephrol; 2015; 41(3):200-9. PubMed ID: 25871915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CHA
    Beyer-Westendorf J; Kreutz R; Posch F; Ay C
    Int J Cardiol; 2018 Feb; 253():71-77. PubMed ID: 29306476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.
    Tabibzadeh N; Wagner S; Metzger M; Flamant M; Houillier P; Boffa JJ; Vrtovsnik F; Thervet E; Stengel B; Haymann JP;
    Am J Kidney Dis; 2019 May; 73(5):596-604. PubMed ID: 30777634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
    Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
    Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Dietary Potassium Intake with the Development of Chronic Kidney Disease and Renal Function in Patients with Mildly Decreased Kidney Function: The Korean Multi-Rural Communities Cohort Study.
    Mun KH; Yu GI; Choi BY; Kim MK; Shin MH; Shin DH
    Med Sci Monit; 2019 Feb; 25():1061-1070. PubMed ID: 30733429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney Function After a Hypertensive Disorder of Pregnancy: A Longitudinal Study.
    Paauw ND; van der Graaf AM; Bozoglan R; van der Ham DP; Navis G; Gansevoort RT; Groen H; Lely AT
    Am J Kidney Dis; 2018 May; 71(5):619-626. PubMed ID: 29289477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid hormones associate with risk of incident chronic kidney disease and rapid decline in renal function: a prospective investigation.
    Huang X; Ding L; Peng K; Lin L; Wang T; Zhao Z; Xu Y; Lu J; Chen Y; Wang W; Bi Y; Ning G; Xu M
    J Transl Med; 2016 Dec; 14(1):336. PubMed ID: 27914474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary chloride concentration and progression of chronic kidney disease: results from the KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease.
    Joo YS; Kim J; Park CH; Yun HR; Park JT; Chang TI; Yoo TH; Sung SA; Lee J; Oh KH; Kim SW; Kang SW; Choi KH; Ahn C; Han SH
    Nephrol Dial Transplant; 2021 Mar; 36(4):673-680. PubMed ID: 31848615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
    BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis.
    Bhatraju PK; Zelnick LR; Shlipak M; Katz R; Kestenbaum B
    J Am Soc Nephrol; 2018 Nov; 29(11):2713-2721. PubMed ID: 30287518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study.
    Kikuchi H; Kanda E; Mandai S; Akazawa M; Iimori S; Oi K; Naito S; Noda Y; Toda T; Tamura T; Sasaki S; Sohara E; Okado T; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):55-62. PubMed ID: 26920126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population.
    Piek A; Smit L; Suthahar N; Bakker SJL; de Boer RA; Silljé HHW
    Sci Rep; 2021 Apr; 11(1):8642. PubMed ID: 33883651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease.
    Pastori D; Pignatelli P; Perticone F; Sciacqua A; Carnevale R; Farcomeni A; Basili S; Corazza GR; Davì G; Lip GYH; Violi F;
    Int J Cardiol; 2016 Nov; 223():619-624. PubMed ID: 27565838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
    Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
    Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.